Tech Company Financing Transactions
Sharp Edge Labs Funding Round
Private investors participated in a $2.1 million funding round for Sharp Edge Labs. This venture round was announced by the company on 7/7/2017.
Transaction Overview
Company Name
Announced On
7/7/2017
Transaction Type
Venture Equity
Amount
$2,075,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 12 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2403 Sidney St. 264
Pittsburgh, PA 15203
USA
Pittsburgh, PA 15203
USA
Phone
Website
Email Address
Overview
Sharp Edge is bringing a new class of targeted biosensors to the cellular biology research community. Fluorogenic Activating Protein (or FAPs) provide a more accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and more detailed follow-up.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Sneddon
Chief Technical Officer
Marcel Bruchez
Chief Technical Officer
Alan Waggoner
Browse more venture capital transactions:
Prev: 7/6/2017: Genvid Technologies venture capital transaction
Next: 7/7/2017: Kangarootime venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs